알레르기 진단 및 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Allergy Diagnostics And Treatment Market size is expected to reach USD 100.93 Billion in 2034 from USD 45.48 Billion (2025) growing at a CAGR of 9.26% during 2026-2034.

The global allergy diagnostics and treatment market is experiencing strong growth due to the increasing prevalence of allergic diseases such as asthma, allergic rhinitis, food allergies, and skin allergies. Allergy diagnostic tests help identify allergens that trigger allergic reactions, allowing healthcare providers to develop appropriate treatment plans for patients.

The market growth is driven by rising environmental pollution, changing lifestyles, and increasing exposure to allergens. Advances in diagnostic technologies, such as molecular allergy testing and improved laboratory testing methods, have enhanced the accuracy of allergy detection. Additionally, the development of innovative treatment options, including immunotherapy and targeted therapies, has improved the management of allergic conditions.

In the future, the allergy diagnostics and treatment market is expected to expand significantly as awareness about allergy management increases worldwide. Continued research in allergy treatment, the development of advanced diagnostic tools, and expanding healthcare infrastructure will support market growth. The rising demand for personalized treatment approaches is also expected to create new opportunities in this sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Diagnostics
• Therapeutics

By Allergen Type

• Food
• Inhaled
• Drug
• Other Allergens

By Test Type

• In vivo Test
• In vitro Test

COMPANIES PROFILED

• Pfizer Inc, AbbVie Inc, Sanofi, Thermo Fisher Scientific Inc, Siemens Healthineers, Danaher Corporation, Alcon, bioMrieux, EUROIMMUN Medizinische Labordiagnostika AG, AESKUGROUP GmbH, DASIT Group SPA, Stallergenes Greer, HYCOR Biomedical, Minaris Medical America Inc, Allergy Therapeutics
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET: BY ALLERGEN TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Allergen Type
• 5.2. Food Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Inhaled Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Drug Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Allergens Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type
• 6.2. In vivo Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. In vitro Test Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Allergen Type
  • 7.2.3 By Test Type
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Allergen Type
  • 7.3.3 By Test Type
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Allergen Type
  • 7.4.3 By Test Type
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Allergen Type
  • 7.5.3 By Test Type
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Allergen Type
  • 7.6.3 By Test Type
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ALLERGY DIAGNOSTICS AND TREATMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Pfizer Inc
  • 9.2.2 AbbVie Inc
  • 9.2.3 Sanofi
  • 9.2.4 Thermo Fisher Scientific Inc
  • 9.2.5 Siemens Healthineers
  • 9.2.6 Danaher Corporation
  • 9.2.7 Alcon
  • 9.2.8 BioMerieux
  • 9.2.9 EUROIMMUN Medizinische Labordiagnostika AG
  • 9.2.10 AESKU.GROUP GmbH
  • 9.2.11 DASIT Group SPA
  • 9.2.12 Stallergenes Greer
  • 9.2.13 HYCOR Biomedical
  • 9.2.14 Minaris Medical America Inc
  • 9.2.15 Allergy Therapeutics